User login
Objective To analyze demographics and treatment outcomes in patients with stage IIIA NSCLC at a community cancer center.
Methods We reviewed charts of 226 patients diagnosed with stage IIIA NSCLC from January 2003 to December 2008 treated at our community cancer center. Results Median overall survival for all patients and sequentially and concurrently treated chemoradiation patients were 18 months, and 18 months, and 20 months, respectively. Median overall survival for women and men was 24 months and 16 months, respectively.
Limitations Study design was retrospective and some medical records were not available. However, this population is likely representative of patients treated in similar settings.
Conclusions In our population, advanced age and male gender were associated with lower median survival. Responses to concurrent and sequential chemoradiation seemed to differ based on age group, which may be useful as a prognostic guideline for similar populations.
Funding Helen F Graham Cancer Center and Research Institute
Click on the PDF icon at the top of this introduction to read the full article.
Objective To analyze demographics and treatment outcomes in patients with stage IIIA NSCLC at a community cancer center.
Methods We reviewed charts of 226 patients diagnosed with stage IIIA NSCLC from January 2003 to December 2008 treated at our community cancer center. Results Median overall survival for all patients and sequentially and concurrently treated chemoradiation patients were 18 months, and 18 months, and 20 months, respectively. Median overall survival for women and men was 24 months and 16 months, respectively.
Limitations Study design was retrospective and some medical records were not available. However, this population is likely representative of patients treated in similar settings.
Conclusions In our population, advanced age and male gender were associated with lower median survival. Responses to concurrent and sequential chemoradiation seemed to differ based on age group, which may be useful as a prognostic guideline for similar populations.
Funding Helen F Graham Cancer Center and Research Institute
Click on the PDF icon at the top of this introduction to read the full article.
Objective To analyze demographics and treatment outcomes in patients with stage IIIA NSCLC at a community cancer center.
Methods We reviewed charts of 226 patients diagnosed with stage IIIA NSCLC from January 2003 to December 2008 treated at our community cancer center. Results Median overall survival for all patients and sequentially and concurrently treated chemoradiation patients were 18 months, and 18 months, and 20 months, respectively. Median overall survival for women and men was 24 months and 16 months, respectively.
Limitations Study design was retrospective and some medical records were not available. However, this population is likely representative of patients treated in similar settings.
Conclusions In our population, advanced age and male gender were associated with lower median survival. Responses to concurrent and sequential chemoradiation seemed to differ based on age group, which may be useful as a prognostic guideline for similar populations.
Funding Helen F Graham Cancer Center and Research Institute
Click on the PDF icon at the top of this introduction to read the full article.